A helium-filled sun shade for protecting individuals engaged in outdoor activities.
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 5534552 | Clear non-alcoholic sinus and allergy medication A clear, hypoallergenic sinus and allergy medication is orally administered in an aqueous, liquid dosage form. The formulation provides effective sinus and allergy relief without alcohol or dyes which adversely affect many allergy sufferers. Said relief i... | 07/09/1996 |
| 5514665 | Method of preventing or reducing the risk of infection by bacterial pathogens utilizing simple and conjugated dextrans Methods for reducing the risk of or preventing infections by bacterial pathogens in vivo. In particular, a method for reducing the risk of P. aeruginosa infection in vivo in compromised hosts such as cystic fibrosis patients. The methods involve the use o... | 05/07/1996 |
| 5441938 | Factors which regulate macrophage antibacterial activity A novel therapy for Pseudomonas aeruginosa infections, in particular in cystic fibrosis patients, is described. Macrophages provide the first line of defence in protecting the lung against bacterial infections. Nonetheless, Pseudomonas aeruginosa infectio... | 08/15/1995 |
| 5409907 | Aqueous pharmaceutical suspension for pharmaceutical actives The present invention relates to an aqueous pharmaceutical suspension composition comprising: from about 0.2% to 20% of a substantially water soluble pharmaceutical active, e.g. acetaminophen; a suspension stabilizing effective amount of xanthan gum and m... | 04/25/1995 |
| 5322689 | Topical aromatic releasing compositions The present invention relates to topical aromatic releasing compositions substantially free from petrolatum and containing one or more volatile aromatic compounds selected from the group consisting of menthol, camphor and eucalyptus oil and mixtures there... | 06/21/1994 |
| 5314697 | Stable extended release oral dosage composition comprising loratadine and pseudoephedrine A film-coated extended release oral dosage composition containing the nasal decongestant pseudoephedrine sulfate in a unique polymer matrix core and a film-coating on such core containing the non-sedating antihistamine, loratadine, and use of the said com... | 05/24/1994 |
| 5272137 | Aqueous pharmaceutical suspension for pharmaceutical actives The present invention relates to an aqueous pharmaceutical suspension composition comprising: from about 0.2% to 20% of a substantially water soluble pharmaceutical active, e.g. acetaminophen; a suspension stabilizing effective amount of xanthan gum and m... | 12/21/1993 |
| 5260073 | Use of phenylpropanolamine as a mucus secretogogue in the upper airways The present invention encompasses the novel method of using b1;phenylpropanolamine to induce mucous secretion in the upper airways of persons afflicted with sinusitis or otitis media characterized by retention of thickened respiratory secretions. These ... | 11/09/1993 |
| 5085865 | Sustained release pharmaceutical preparations containing an analgesic and a decongestant An orally administrable sustained-release pharmaceutical tablet having at least two layers, which are directly compressible, is disclosed. The first layer, an immediate-release layer, contains an orally active analgesic and is readily susceptible to disin... | 02/04/1992 |
| 5013716 | Unpleasant taste masking compositions and methods for preparing same The present invention pertains to an unpleasant taste masking composition which comprises a flavoring agent having a bitter taste or unpleasant off-note and a sufficient amount of a non-bitter intense sweetener to nullify the taste or off-note of the flav... | 05/07/1991 |
| 4971798 | Hard confections containing hydrogenated isomaltulose and medicinally active ingredient Disclosed is a hard confection containing Palatinit (hydrogenated isomaltulose) and a medicinally active ingredient. Such a formulation has been found to dissolve more slowly than similar formulations based on sugar rendering them suitable for dispensing ... | 11/20/1990 |
| 4970240 | Fruity flavored nasal decongestant composition An aqueous, flavored, topical, nasal decongestant composition containing an amount of oxymetazoline or a pharmaceutically acceptable salt thereof, e.g., oxymetazoline HCl sufficient to effect nasal decongestion and an amount of a fruity flavor e.g. cherry... | 11/13/1990 |
| 4826683 | Decongestant A decongestant is disclosed consisting essentially of active components of from about 2 g to about 10 g of vegetable oil, from about 0.1 g to about 5 g of aloe vera, from about 3 mg to about 150 mg of zinc, from about 10 mg to about 1000 mg of vitamin C, ... | 05/02/1989 |
| 4767612 | Triamcinolone acetonide for the treatment of allergic rhinitis Disclosed is a method for the treatment of allergic rhinitis that manifests itself as rhinorrhea, nasal itching, sneezing, congestion and postnasal drip. The method comprises the administration from a nasal aerosol dispenser an effective amount of microni... | 08/30/1988 |
| 4762719 | Powder filled cough product A cough drop is provided comprising a hard candy outer shell and a powdered centerfill containing a rapidly-dissolving powder such as dextrose monohydrate and an active ingredient such as menthol and eucalyptus which is preferably in the form of a liquid ... | 08/09/1988 |
| 4758424 | Medicament adsorbates of decongestants with complex magnesium aluminum silicate and their preparation A medicament adsorbate of decongestants and process for making same. The medicament adsorbate comprises a complex magnesium aluminum silicate having sorbed therein a decongestant. The complex magnesium aluminum silicate has the following typical chemical ... | 07/19/1988 |
| 4737519 | Substituted naphthalenes, indoles, benzofurans, and benzothiophenes as lipoxygenase inhibitors The present invention provides certain novel substituted naphthalenes, indoles, benzofurans, and benzothiophenes of Formula I which are useful as inhibitors of leukotriene biosynthesis and as inhibitors of lipoxygenase. They are thus employed wherever it ... | 04/12/1988 |
| 4632821 | Magnesium trisilicate suitable for preparation of medicament adsorbates of decongestants A medicament adsorbate containing a magnesium trisilicate having a surface area of at least 400 m2 /g and having a flake-like structure with multiple interstitial spaces, and having adsorbed therein from about 1% to about 20% by weight of the a... | 12/30/1986 |
| 4560553 | Use of eucalyptol for enhancing skin permeation of bio-affecting agents Eucalyptol is used to enhance skin permeation of bio-affecting agents.... | 12/24/1985 |
| 4209639 | 13-Thia-prostaglandins This disclosure describes novel 13-thia prostanoic acids and derivatives thereof useful in causing prostaglandin-like biological responses.... | 06/24/1980 |
| 4049648 | PG-type, 1,9-lactones The present invention provides novel 1,9 lactones of prostaglandin-type free acids and a process for their preparation. These lactones are useful for the same pharmacological purposes as the corresponding prostaglandin-type free acids.... | 09/20/1977 |
| 3965167 | Crystalline ammonium N-acetyl-L-cysteinate and mucolytic process The ammonium salt of N-acetyl-L-cysteine is a relatively non-hygroscopic crystalline solid which renders it particularly useful for administration by insufflation in the treatment of bronchopulmonary disease. It is of use in a mucolytic process wherein br... | 06/22/1976 |